Gland Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 1,093.58 | 1,074.07 | 1,075.85 |
| Operating Expense | 679.99 | 636.23 | 619.64 |
| Net Profit | 269.26 | 290 | 295.12 |
| Net Profit Margin | 24.62 | 27.00 | 27.43 |
| Earning Per Share | 16.34 | 17.60 | 17.91 |
| EBIDTA | 413.74 | 435.59 | 452.29 |
| Effective Tax Rate | 22.55 | 22.63 | 20.84 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 1093.58 |
| Operating Expense | 679.99 |
| Net Profit | 269.26 |
| Net Profit Margin | 24.62 |
| Earning Per Share | 16.34 |
| EBIDTA | 413.74 |
| Effective Tax Rate | 22.55 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 4,116.15 | 4,167.43 | 3,616.53 |
| Operating Expenses Annual | 2,673.53 | 2,758.65 | 2,597.98 |
| Operating Profit Annual | 1,657.69 | 1,575.45 | 1,202.55 |
| Interest Annual | 22.84 | 7.84 | 7.41 |
| Depreciation | 164.47 | 157.99 | 145.68 |
| Net Profit Annual | 1,089.75 | 1,043.33 | 775.83 |
| Tax Annual | 375.83 | 362.17 | 272.58 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 4,116.15 |
| Operating Expenses Annual | 2,673.53 |
| Operating Profit Annual | 1,657.69 |
| Interest Annual | 22.84 |
| Depreciation | 164.47 |
| Net Profit Annual | 1,089.75 |
| Tax Annual | 375.83 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 116.21 | 1,905.22 | 311.18 |
| Cash Flow from Operations | 1,073.67 | 1,135.97 | 367.89 |
| Cash Flow from Investing | 1,582.29 | -2,917.58 | 1,211.22 |
| Cash Flow from Financing | -339.54 | -7.40 | 14.92 |
| Cash Flow at the End | 2,432.62 | 116.21 | 1,905.22 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 116.21 |
| Cash Flow from Operations | 1,073.67 |
| Cash Flow from Investing | 1,582.29 |
| Cash Flow from Financing | -339.54 |
| Cash Flow at the End | 2,432.62 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 40.27 | 37.80 | 33.25 |
| PBIT Margin (%) | 36.16 | 33.91 | 29.19 |
| PBT Margin (%) | 34.58 | 29.58 | 25.25 |
| Net PROFIT Margin (%) | 26.47 | 25.04 | 21.45 |
| Return On Networth / Equity (%) | 11.62 | 12.31 | 10.27 |
| Return On Networth /Employed (%) | 15.83 | 16.65 | 13.96 |
| Return On Assets (%) | 11.65 | 12.27 | 10.30 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.44 | 0.49 | 0.48 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 40.27 |
| PBIT Margin (%) | 36.16 |
| PBT Margin (%) | 34.58 |
| Net PROFIT Margin (%) | 26.47 |
| Return On Networth / Equity (%) | 11.62 |
| Return On Networth /Employed (%) | 15.83 |
| Return On Assets (%) | 11.65 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.44 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 1,744.99 | 1,693.73 | 1,570.55 |
| Total Current Assets Annual | 5,766.96 | 4,571.33 | 6,888.34 |
| Non Current Assets Annual | 4,654.66 | 4,969.76 | 1,884.84 |
| Total Shareholders Funds Annual | 9,755.10 | 8,995.29 | 7,953.30 |
| Total Assets Annual | 10,421.62 | 9,541.09 | 8,773.18 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 1,744.99 |
| Total Current Assets Annual | 5,766.96 |
| Non Current Assets Annual | 4,654.66 |
| Total Shareholders Funds Annual | 9,755.10 |
| Total Assets Annual | 10,421.62 |
EPS (INR)
Expected
13.08
Reported
13.08
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
